Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F ROUSSEL

Showing results (281-290 of 306) with videos related to

Pageof 31
Sort By:
Acta Neuropathologica Communications|July 28, 2025
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumorsRebecca R J Collins, Rebecca R Florke Gee, Sima Tozandehjani, et al.
Science Translational Medicine|November 1, 2023
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastomaMinsoo Khang, Ju Hyun Lee, Teresa Lee, et al.
Oncogene|May 16, 2017
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cellsD Kawauchi, R J Ogg, L Liu, et al.
Journal of Medicinal Chemistry|January 15, 2025
Evaluation of Cereblon-Directing Warheads for the Development of Orally Bioavailable PROTACsMarisa Actis, Joel Cresser-Brown, Elizabeth A Caine, et al.
Nature Communications|February 10, 2023
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instabilityZaili Luo, Dazhuan Xin, Yunfei Liao, et al.
Nature Communications|April 7, 2026
PHIP suppresses NuRD to enable the growth of SWI/SNF-mutant cancersHayden A Malone, Jacquelyn A Myers, Emma G Gruss, et al.
Journal of Medicinal Chemistry|May 27, 2021
Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon ModulatorsGisele Nishiguchi, Fatemeh Keramatnia, Jaeki Min, et al.
Journal of Neuro-Oncology|May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cellsGintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Nature Communications|April 25, 2024
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibitionNoha A M Shendy, Melissa Bikowitz, Logan H Sigua, et al.
Angewandte Chemie (International Ed. in English)|October 6, 2021
Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACsJaeki Min, Anand Mayasundari, Fatemeh Keramatnia, et al.
Pageof 31

Showing results (281-290 of 306) with videos related to

Sort By:
Pageof 31
Acta Neuropathologica Communications|July 28, 2025
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumorsRebecca R J Collins, Rebecca R Florke Gee, Sima Tozandehjani, et al.
Science Translational Medicine|November 1, 2023
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastomaMinsoo Khang, Ju Hyun Lee, Teresa Lee, et al.
Oncogene|May 16, 2017
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cellsD Kawauchi, R J Ogg, L Liu, et al.
Journal of Medicinal Chemistry|January 15, 2025
Evaluation of Cereblon-Directing Warheads for the Development of Orally Bioavailable PROTACsMarisa Actis, Joel Cresser-Brown, Elizabeth A Caine, et al.
Nature Communications|February 10, 2023
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instabilityZaili Luo, Dazhuan Xin, Yunfei Liao, et al.
Nature Communications|April 7, 2026
PHIP suppresses NuRD to enable the growth of SWI/SNF-mutant cancersHayden A Malone, Jacquelyn A Myers, Emma G Gruss, et al.
Journal of Medicinal Chemistry|May 27, 2021
Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon ModulatorsGisele Nishiguchi, Fatemeh Keramatnia, Jaeki Min, et al.
Journal of Neuro-Oncology|May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cellsGintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Nature Communications|April 25, 2024
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibitionNoha A M Shendy, Melissa Bikowitz, Logan H Sigua, et al.
Angewandte Chemie (International Ed. in English)|October 6, 2021
Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACsJaeki Min, Anand Mayasundari, Fatemeh Keramatnia, et al.
Pageof 31